On July 4, President Donald Trump signed into law the One Big Beautiful Bill Act (OBBBA). This alert summarizes the key changes under the OBBBA relevant to private equity sponsors and their investors, as well as some of the...more
7/28/2025
/ Bonus Depreciation ,
Business Taxes ,
Carried Interest ,
EBITDA ,
Interest Rates ,
Internal Revenue Code (IRC) ,
International Tax Issues ,
New Legislation ,
One Big Beautiful Bill Act ,
Private Equity ,
Qualified Business Income ,
Qualified Small Business Stock ,
Renewable Energy ,
Research and Experiment Tax Credit ,
Tax Credits ,
Tax Cuts and Jobs Act ,
Tax Deductions ,
Tax Legislation ,
Tax Planning ,
Tax Reform
As we previously discussed (here and here), the biotech mergers and acquisitions market currently faces significant headwinds. These challenges include frozen capital markets, regulatory uncertainty at the Food and Drug...more
6/10/2025
/ Acquisitions ,
Biotechnology ,
Capital Markets ,
Corporate Governance ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Initial Public Offering (IPO) ,
Mergers ,
Pharmaceutical Industry ,
Securities and Exchange Commission (SEC) ,
Shareholders ,
Spinoffs ,
Tax Planning ,
Tax-Free Spin-Offs